Postmenopausal hormone therapy and body composition—a substudy of the estrogen plus progestin trial of the Women’s Health Initiative

Gambacciani, 2001, Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapy, Maturitas, 39, 125, 10.1016/S0378-5122(01)00194-3 Sorensen, 2001, Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy, Obes Res, 9, 622, 10.1038/oby.2001.81 Kristensen, 1999, Hormone replacement therapy affects body composition and leptin differently in obese and non-obese postmenopausal women, J Endocrinol, 163, 55, 10.1677/joe.0.1630055 Rossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001/jama.288.3.321 The Women’s Health Initiative Study Group, 1998, Design of the Women’s Health Initiative clinical trial and observational study, Control Clin Trials, 19, 61, 10.1016/S0197-2456(97)00078-0 Block, 1990, Validation of a self-administered diet history questionnaire using multiple diet records, J Clin Epidemiol, 43, 1327, 10.1016/0895-4356(90)90099-B Patterson, 1996, Low-fat diet practices of older women: prevalence and implications for dietary assessment, J Am Diet Assoc, 96, 670, 10.1016/S0002-8223(96)00186-1 Ainsworth, 1993, Compendium of physical activities: classification of energy costs of human physical activities, Med Sci Sports Exerc, 25, 71, 10.1249/00005768-199301000-00011 Ware, 1992, The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection, Med Care, 30, 473, 10.1097/00005650-199206000-00002 Espeland, 1997, Effect of postmenopausal hormone therapy on body weight and waist and hip girths, J Clin Endocrinol Metab, 82, 1549 Jensen, 2003, Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study, J Bone Miner Res, 18, 333, 10.1359/jbmr.2003.18.2.333 Ijuin, 1999, The contribution of menopause to changes in body-fat distribution, J Obstet Gynaecol Res, 25, 367, 10.1111/j.1447-0756.1999.tb01178.x Aloia, 1995, The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass, Am J Obstet Gynecol, 172, 896, 10.1016/0002-9378(95)90018-7 Gambacciani, 1997, Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women, J Clin Endocrinol Metab, 82, 414, 10.1210/jcem.82.2.3735 Davis, 2000, Effects of estradiol with and without testosterone on body composition and relationships with lipids in postmenopausal women, Menopause, 7, 395, 10.1097/00042192-200011000-00005 Reubinoff, 1995, Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: a prospective study, Fertil Steril, 64, 963, 10.1016/S0015-0282(16)57910-2 Perrone, 1999, Evaluation of the body composition and fat distribution in long-term users of hormone replacement therapy, Gynecol Obstet Invest, 48, 52, 10.1159/000010134 Samaras, 1998, Tobacco smoking and oestrogen replacement are associated with lower total and central fat in monozygotic twins, Int J Obes Relat Metab Disord, 22, 149, 10.1038/sj.ijo.0800558 Greenfield, 2003, Moderate alcohol consumption, estrogen replacement therapy, and physical activity are associated with increased insulin sensitivity: is abdominal adiposity the mediator?, Diabetes Care, 26, 2734, 10.2337/diacare.26.10.2734 Margolis, 2004, Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women’s Health Initiative Hormone Trial, Diabetologia, 47, 1175, 10.1007/s00125-004-1448-x Jensen, 1986, Oestrogen-progestogen replacement therapy changes body composition in early post-menopausal women, Maturitas, 8, 209, 10.1016/0378-5122(86)90028-9 Dittmar, 2001, Comparison of soft tissue body composition in postmenopausal women with or without hormone replacement therapy considering the influence of reproductive history and lifestyle, Ann Hum Biol, 28, 207, 10.1080/03014460151056437 Bemben, 2002, Relationship between estrogen use and musculoskeletal function in postmenopausal women, Maturitas, 42, 119, 10.1016/S0378-5122(02)00033-6 Sarrel, 1998, Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses, J Reprod Med, 43, 847 Chang, 2002, Plasma concentrations of insulin-like growth factors among healthy adult men and postmenopausal women: associations with body composition, lifestyle, and reproductive factors, Cancer Epidemiol Biomarkers Prev, 11, 758 Hartmann, 1995, Effects of hormone replacement therapy on growth hormone secretion patterns in correlation to somatometric parameters in healthy postmenopausal women, Maturitas, 22, 239, 10.1016/0378-5122(95)00942-E Cauley, 2003, Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trial, JAMA, 290, 1729, 10.1001/jama.290.13.1729